helptariff
台湾 → 美国HS 300490其他麻醉剂建议委托报关行

의료용품(ko) › Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses or in forms or(en)

其他麻醉剂

HS 300490台湾 → 美国

目的国关税
0%
普通
联邦增值税（VAT/GST）
无
通关难度
建议委托报关行

1概览

  • 目的国关税: Free (普通, 3004.90.10.00) — 与台湾无优惠协定，适用基本／最惠国税率。
  • 联邦增值税（VAT/GST）: 无 — 美国没有联邦增值税；各州销售税不在进口环节征收。
  • 该编码涵盖: 其他麻醉剂
  • 额外关税: 额外关税（HTSUS 第99章：Section 232／301／122）可能在上列税率之上加征 — 请以报关日的第99章注释为准。
  • 需留意的制度: US duty-free de minimis suspended for all countriesSince 2025-08-29 Executive Order 14324 has suspended duty-free de minimis entry for shipments from every country. Parcels are now dutiable and need an entry with HS classification and origin, which structurally raises difficulty for small consignments.federalregister.gov

要点

  • 小额免税已无限期暂停：邮递以外方式自 2026-06-24 起，国际邮递自 2026-07-24 起。800 美元免税通关已不存在。
  • 没有联邦增值税；各州销售税或使用税属于进口之后的另一件事，海关不代征。
  • 2,500 美元是简易报关与正式报关的分界。价值 2,500 美元及以下且属 HTSUS 第 1 至 97 章的邮递货物，可适用新设的邮递简易报关程序，关税应于货物抵达次月 7 日前缴纳。
  • 进口商（importer of record）可自行在 ACE 申报，但正式报关须有海关保证金（customs bond），海运货物还须在装船前 24 小时完成进口商安全申报（ISF 10+2）。
  • 额外关税可能以第 99 章项目征收。截至 2026-09，请按报关日核实第 232 条、第 301 条及施行中的附加关税，不要沿用此前引用的数字。

数据日期: 2026 HTS Rev.15

2归类

HS6 品名

  • ko기타
  • enOther anesthetics
  • zh_hant其他麻醉劑
  • zh_hans其他麻醉剂

美国 税则子目

子目品名
3004.90.10.00Containing antigens or hyaluronic acid or its sodium saltMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other
3004.90.92OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other
3004.90.92.01For veterinary useMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other
3004.90.92.03Containing acyclovir or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Anti-infective medicaments › Antivirals
3004.90.92.04Containing oseltamivir or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Anti-infective medicaments › Antivirals
3004.90.92.05Containing valganciclovir, peramivir or their saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Anti-infective medicaments › Antivirals
3004.90.92.06OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Anti-infective medicaments › Antivirals
3004.90.92.07Containing fluconazole or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Anti-infective medicaments › Antifungals
3004.90.92.08OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Anti-infective medicaments › Antifungals
3004.90.92.09Containing metronidazole or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Anti-infective medicaments › Antiprotozoals (excluding goods described in subheading note 2 to this ch…
3004.90.92.10OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Anti-infective medicaments › Antiprotozoals (excluding goods described in subheading note 2 to this ch…
3004.90.92.11Containing trimethoprim and sulfamethoxazole or their saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Anti-infective medicaments › Sulfonamides
3004.90.92.12OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Anti-infective medicaments › Sulfonamides
3004.90.92.13Containing levofloxacin or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Anti-infective medicaments › Other
3004.90.92.14Containing linezolid or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Anti-infective medicaments › Other
3004.90.92.15OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Anti-infective medicaments › Other
3004.90.92.16Containing hydroxyurea or cyclophosphamide or their saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Antineoplastic and immunosuppressive medicaments
3004.90.92.17Containing tacrolimus or mycophenolate mofetil or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Antineoplastic and immunosuppressive medicaments
3004.90.92.18OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Antineoplastic and immunosuppressive medicaments
3004.90.92.19Containing metoprolol or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Cardiovascular medicaments
3004.90.92.20Containing amiodarone or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Cardiovascular medicaments
3004.90.92.21Containing diltiazem or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Cardiovascular medicaments
3004.90.92.22Containing hydralazine or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Cardiovascular medicaments
3004.90.92.23Containing enoxaparin or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Cardiovascular medicaments
3004.90.92.24Containing labetalol or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Cardiovascular medicaments
3004.90.92.25Containing argatroban, adenosine, amlodipine, esmolol, dobutamine, phenoxybenzamine or their saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Cardiovascular medicaments
3004.90.92.26OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Cardiovascular medicaments
3004.90.92.27TolmetinMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Analgesics, antipyretics and nonhormonal …
3004.90.92.28Tolmetin sodium dihydrateMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Analgesics, antipyretics and nonhormonal …
3004.90.92.29Tolmetin sodium (anhydrous)Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Analgesics, antipyretics and nonhormonal …
3004.90.92.30For oral suspensionMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Analgesics, antipyretics and nonhormonal …
3004.90.92.31OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Analgesics, antipyretics and nonhormonal …
3004.90.92.32For oral suspensionMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Analgesics, antipyretics and nonhormonal …
3004.90.92.33OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Analgesics, antipyretics and nonhormonal …
3004.90.92.34Containing O-Acetylsalicylic acid (Aspirin)Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Analgesics, antipyretics and nonhormonal …
3004.90.92.35Containing tramadolMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Analgesics, antipyretics and nonhormonal …
3004.90.92.36OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Analgesics, antipyretics and nonhormonal …
3004.90.92.37Containing dexmedetomidine, etomidate, midazolam, propofol or their saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Anticonvulsants, hypnotics and sedatives
3004.90.92.38Containing midazolam or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Anticonvulsants, hypnotics and sedatives
3004.90.92.39Containing phenytoin or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Anticonvulsants, hypnotics and sedatives
3004.90.92.40Containing propofol or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Anticonvulsants, hypnotics and sedatives
3004.90.92.41Containing levetiracetam, phenytoin or their saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Anticonvulsants, hypnotics and sedatives
3004.90.92.42Containing etomidate or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Anticonvulsants, hypnotics and sedatives
3004.90.92.43OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Anticonvulsants, hypnotics and sedatives
3004.90.92.44Containing lorazepam or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Antidepressants, tranquilizers, and other…
3004.90.92.45Containing olanzapine or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Antidepressants, tranquilizers, and other…
3004.90.92.46OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Antidepressants, tranquilizers, and other…
3004.90.92.47Containing rocuronium or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Other
3004.90.92.48Containing succinylcholine or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Other
3004.90.92.49OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Other
3004.90.92.50Containing lidocaine or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Dermatological agents and local anesthetics
3004.90.92.51OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Dermatological agents and local anesthetics
3004.90.92.52LaxativesMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the digestive system
3004.90.92.53AntacidsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the digestive system
3004.90.92.54Containing famotidine or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the digestive system
3004.90.92.55Containing pantoprazole or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the digestive system
3004.90.92.56Containing ondansetron or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the digestive system
3004.90.92.57Containing glycopyrrolate or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the digestive system
3004.90.92.58Containing loperamide or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the digestive system
3004.90.92.60OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the digestive system
3004.90.92.61Containing furosemide and its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Preparations primarily affecting the electrolytic, caloric or water balance › Diuretics
3004.90.92.62Containing hydrochlorothiazide or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Preparations primarily affecting the electrolytic, caloric or water balance › Diuretics
3004.90.92.63OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Preparations primarily affecting the electrolytic, caloric or water balance › Diuretics
3004.90.92.64Containing calcium gluconateMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Preparations primarily affecting the electrolytic, caloric or water balance › Other
3004.90.92.65Containing potassium chlorideMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Preparations primarily affecting the electrolytic, caloric or water balance › Other
3004.90.92.66Containing sodium bicarbonate, in injection formMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Preparations primarily affecting the electrolytic, caloric or water balance › Other
3004.90.92.67OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Preparations primarily affecting the electrolytic, caloric or water balance › Other
3004.90.92.68Cough and cold preparationsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the eyes, ears, or respiratory system
3004.90.92.69Containing diphenhydramine or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the eyes, ears, or respiratory system › Other › Antihistamines
3004.90.92.70OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the eyes, ears, or respiratory system › Other › Antihistamines
3004.90.92.71Containing albuterol sulfateMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the eyes, ears, or respiratory system › Other
3004.90.92.72Containing timolol maleateMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the eyes, ears, or respiratory system › Other › Other
3004.90.92.73OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the eyes, ears, or respiratory system › Other › Other
3004.90.92.74Containing heparin sodium or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Other
3004.90.92.75Containing zoledronic acid or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Other
3004.90.92.76OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Other
台湾 出口侧编码（参考）
  • 30049010107醫藥製劑，含有硫美妥者（包括異構物、酯類、醚類及鹽類）
  • 30049010205醫藥製劑，含有愷他命及其異構物、酯類、醚類及鹽類者
  • 30049010303醫藥製劑，含有丙泊酚、依托咪酯，及其異構物、酯類、醚類及鹽類者
  • 30049010900其他麻醉劑
  • 30049020007血液代用品與血漿代用品及基因重組製劑
  • 30049030005營養與電解質液
  • 30049040003洗腎用清洗液，具有劑量或零售包裝式樣者
  • 30049050000磺胺藥
  • 30049061007中藥酒劑
  • 30049069009其他中藥製劑
  • 30049071005抗癌藥
  • 30049072004抗人類免疫缺乏病毒感染用藥
  • 30049080004農藥中毒解毒劑
  • 30049091001抗排斥醫藥製劑
  • 30049092000安瓿裝蒸餾水
  • 30049099101抗過敏抗組織胺用藥
  • 30049099218醫藥製劑，含有西可巴比妥者
  • 30049099227醫藥製劑，含有異戊巴比妥者
  • 30049099316醫藥製劑，含有三唑他（三唑侖）者
  • 30049099325醫藥製劑，含有氟硝西泮者
  • 30049099334醫藥製劑，含有氯甲西泮（甲基樂耐平）者
  • 30049099343醫藥製劑，含有氟地西泮（氟二氮平）者
  • 30049099352醫藥製劑，含有舒樂安定（伊疊唑侖）者
  • 30049099361醫藥製劑，含有阿普唑他（三氮二氮平）者
  • 30049099370醫藥製劑，含有替馬西泮（甲羥氮平）者
  • 30049099389醫藥製劑，含有咪達唑他（咪氟唑侖）者
  • 30049099414醫藥製劑，含有特拉嗎竇者
  • 30049099423醫藥製劑，含有伯替唑他者
  • 30049099432醫藥製劑，含有唑匹可隆者
  • 30049099441玻璃體替代物
  • 30049099450醫藥製劑，含有札來普隆者
  • 30049099469醫藥製劑，含有佐沛眠者
  • 30049099520醫藥製劑，含有瑞吩坦尼及其異構物、酯類、醚類及鹽類者
  • 30049099539醫藥製劑，含有阿華吩坦尼及其異構物、酯類、醚類及鹽類者
  • 30049099548醫藥製劑，含有吩坦尼及其異構物、酯類、醚類及鹽類者
  • 30049099557醫藥製劑，含有美沙冬及其異構物、酯類、醚類及鹽類者
  • 30049099566醫藥製劑，含有潘他唑新及其異構物、酯類、醚類及鹽類者
  • 30049099575醫藥製劑，含有蘇吩坦尼及其異構物、酯類、醚類及鹽類者
  • 30049099584醫藥製劑，含有四氫大麻酚及其異構物、酯類、醚類及鹽類者
  • 30049099593醫藥製劑，含有派醋甲酯及其異構物、酯類、醚類及鹽類者
  • 30049099619醫藥製劑，含有他噴他竇及其異構物、酯類、醚類及鹽類者
  • 30049099628醫藥製劑，含有戊巴比妥（不含異戊巴比妥）及其異構物、酯類、醚類及鹽類者
  • 30049099637醫藥製劑，含有硝甲西泮（硝甲氮平）及其異構物、酯類、醚類及鹽類者
  • 30049099646醫藥製劑，含有巴比妥及其異構物、酯類、醚類及鹽類者
  • 30049099655醫藥製劑，含有溴西泮（溴氮平）及其異構物、酯類、醚類及鹽類者
  • 30049099664醫藥製劑，含有勞拉西泮（樂耐平）及其異構物、酯類、醚類及鹽類者
  • 30049099673醫藥製劑，含有美達西泮（美達氮平）及其異構物、酯類、醚類及鹽類者
  • 30049099682醫藥製劑，含有甲丙氨酯（美普巴邁）及其異構物、酯類、醚類及鹽類者
  • 30049099691醫藥製劑，含有硝西泮（耐妥眠）及其異構物、酯類、醚類及鹽類者
  • 30049099717醫藥製劑，含有去甲西泮（原氮平）及其異構物、酯類、醚類及鹽類者
  • 30049099726醫藥製劑，含有去甲羥安定（歐沙氮平、去甲羥氮平）及其異構物、酯類、醚類及鹽類者
  • 30049099735醫藥製劑，含有噁唑他（㗁甲唑侖）及其異構物、酯類、醚類及鹽類者
  • 30049099744醫藥製劑，含有匹嗎啉（苯㗁唑啉）及其異構物、酯類、醚類及鹽類者
  • 30049099753醫藥製劑，含有氯巴占（甲酮氮平）及其異構物、酯類、醚類及鹽類者
  • 30049099762醫藥製劑，含有氯硝西泮（可那氮平、氯硝氮平）及其異構物、酯類、醚類及鹽類者
  • 30049099771醫藥製劑，含有氯拉䓬酸（氯氮平酸鹽）及其異構物、酯類、醚類及鹽類者
  • 30049099780醫藥製劑，含有氯噁唑他（氯㗁唑侖）及其異構物、酯類、醚類及鹽類者
  • 30049099799醫藥製劑，含有安定（二氮平）及其異構物、酯類、醚類及鹽類者
  • 30049099815醫藥製劑，含有氟安定（氟路洛）及其異構物、酯類、醚類及鹽類者
  • 30049099824醫藥製劑，含有普拉西泮（環丙氮平）及其異構物、酯類、醚類及鹽類者
  • 30049099833醫藥製劑，含有莫待芬寧及其異構物、酯類、醚類及鹽類者
  • 30049099842醫藥製劑，含有美妥芬諾及其異構物、酯類、醚類及鹽類者
  • 30049099851醫藥製劑，含有氯苄雷司及其異構物、酯類、醚類及鹽類者
  • 30049099860醫藥製劑，含有離胺右旋安非他命及其異構物、酯類、醚類及鹽類者
  • 30049099904其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者

美国 案例前三条

不是你的商品？重新搜索

数据日期: 2026 HTS Rev.15

3关税与税费

与台湾无优惠协定，适用基本／最惠国税率。

子目品名普通优惠（special）Column 2
3004.90.10.00Containing antigens or hyaluronic acid or its sodium saltFree—Free
3004.90.92OtherFree—30%
3004.90.92.01For veterinary use———
3004.90.92.03Containing acyclovir or its salts———
3004.90.92.04Containing oseltamivir or its salts———
3004.90.92.05Containing valganciclovir, peramivir or their salts———
3004.90.92.06Other———
3004.90.92.07Containing fluconazole or its salts———
3004.90.92.08Other———
3004.90.92.09Containing metronidazole or its salts———
3004.90.92.10Other———
3004.90.92.11Containing trimethoprim and sulfamethoxazole or their salts———
3004.90.92.12Other———
3004.90.92.13Containing levofloxacin or its salts———
3004.90.92.14Containing linezolid or its salts———
3004.90.92.15Other———
3004.90.92.16Containing hydroxyurea or cyclophosphamide or their salts———
3004.90.92.17Containing tacrolimus or mycophenolate mofetil or its salts———
3004.90.92.18Other———
3004.90.92.19Containing metoprolol or its salts———
3004.90.92.20Containing amiodarone or its salts———
3004.90.92.21Containing diltiazem or its salts———
3004.90.92.22Containing hydralazine or its salts———
3004.90.92.23Containing enoxaparin or its salts———
3004.90.92.24Containing labetalol or its salts———
3004.90.92.25Containing argatroban, adenosine, amlodipine, esmolol, dobutamine, phenoxybenzamine or their salts———
3004.90.92.26Other———
3004.90.92.27Tolmetin———
3004.90.92.28Tolmetin sodium dihydrate———
3004.90.92.29Tolmetin sodium (anhydrous)———
3004.90.92.30For oral suspension———
3004.90.92.31Other———
3004.90.92.32For oral suspension———
3004.90.92.33Other———
3004.90.92.34Containing O-Acetylsalicylic acid (Aspirin)———
3004.90.92.35Containing tramadol———
3004.90.92.36Other———
3004.90.92.37Containing dexmedetomidine, etomidate, midazolam, propofol or their salts———
3004.90.92.38Containing midazolam or its salts———
3004.90.92.39Containing phenytoin or its salts———
3004.90.92.40Containing propofol or its salts———
3004.90.92.41Containing levetiracetam, phenytoin or their salts———
3004.90.92.42Containing etomidate or its salts———
3004.90.92.43Other———
3004.90.92.44Containing lorazepam or its salts———
3004.90.92.45Containing olanzapine or its salts———
3004.90.92.46Other———
3004.90.92.47Containing rocuronium or its salts———
3004.90.92.48Containing succinylcholine or its salts———
3004.90.92.49Other———
3004.90.92.50Containing lidocaine or its salts———
3004.90.92.51Other———
3004.90.92.52Laxatives———
3004.90.92.53Antacids———
3004.90.92.54Containing famotidine or its salts———
3004.90.92.55Containing pantoprazole or its salts———
3004.90.92.56Containing ondansetron or its salts———
3004.90.92.57Containing glycopyrrolate or its salts———
3004.90.92.58Containing loperamide or its salts———
3004.90.92.60Other———
3004.90.92.61Containing furosemide and its salts———
3004.90.92.62Containing hydrochlorothiazide or its salts———
3004.90.92.63Other———
3004.90.92.64Containing calcium gluconate———
3004.90.92.65Containing potassium chloride———
3004.90.92.66Containing sodium bicarbonate, in injection form———
3004.90.92.67Other———
3004.90.92.68Cough and cold preparations———
3004.90.92.69Containing diphenhydramine or its salts———
3004.90.92.70Other———
3004.90.92.71Containing albuterol sulfate———
3004.90.92.72Containing timolol maleate———
3004.90.92.73Other———
3004.90.92.74Containing heparin sodium or its salts———
3004.90.92.75Containing zoledronic acid or its salts———
3004.90.92.76Other———

额外关税（HTSUS 第99章：Section 232／301／122）可能在上列税率之上加征 — 请以报关日的第99章注释为准。

  • · 美国没有联邦层级的增值税，海关只征收关税与规费。
  • · 商品处理费（MPF）：正式报关时为申报价格的 0.3464%，并设有每财政年度重新调整的上下限；简易报关按定额收取。
  • · 港口维护费（HMF）：以船舶运抵的货物按价格 0.125% 计收。
  • · 各州销售税或使用税针对货物的后续销售或使用，由各州税务机关管理，与 CBP 无关。
  • · 第 99 章的额外关税（第 232 条、第 301 条及施行中的附加关税）加计于一般税率之上，请按报关日确认适用情况。

税费概算

采用税率
0%
完税价格
—
关税
—
联邦增值税（VAT/GST）
—
预估合计
—

此为概算。实际金额取决于完税价格审定、归类与原产地认定。

数据日期: 2026 HTS Rev.15

4监管要求

  • FD2FDA

    Pharmaceutical products (medicaments, blood, dressings) - FDA-regulated drug/biologic (FD2). Potential/disclaimable flag; submit FDA entry data if FDA-regulated.

    可信度:
    chapter-heuristic
    fda.gov
  • headingDEA

    Medicaments (subset containing controlled substances) - DEA import registration/permit for scheduled-drug content. Substance-dependent, narrow.

    可信度:
    chapter-heuristic
    dea.gov

CBP 未完整公开各 HS 的 PGA 标记，此处以章／品目层级启发式映射。

相关机关

  • 美国海关与边境保护局（CBP）办理进口通关、核定关税与规费，并在口岸执行其他机构的规定cbp.gov
  • 美国国际贸易委员会（USITC）编制并公布 HTSUS，含第 99 章额外关税条款hts.usitc.gov
  • 美国食品药品监督管理局（FDA）食品、药品、医疗器械与化妆品；事先通报与 MoCRA 注册列名fda.gov
  • 美国农业部动植物卫生检验局（APHIS）动植物产品的进口许可与检疫要求aphis.usda.gov
  • 美国联邦通信委员会（FCC）无线电频率设备与设备认证fcc.gov
  • 美国消费品安全委员会（CPSC）消费品与儿童用品认证cpsc.gov

数据日期: 2026-08-27

5单证

台湾 出口单证

  • 出口报单
    签发:
    报关业者或出口人，经关港贸单一窗口传输
    时点:
    货物装运前

    常见报单类别包括本地货物出口与外货复出口，实际代号按关务署规定填报。

    官方页面
  • 商业发票
    签发:
    出口人
    时点:
    报关时

    载明品名、数量、单价、贸易条件与原产地；进口地海关也据以审价。

    官方页面
  • 装箱单
    签发:
    出口人
    时点:
    报关时

    逐箱内容、重量、体积与唛头，查验时使用。

    官方页面
  • 装货单（S/O）
    签发:
    承运人或货运代理
    时点:
    订舱后取得

    作为货物进入码头、集散站与装船的依据。

    官方页面
  • 提单（B/L）或空运单（AWB）
    签发:
    承运人
    时点:
    装运后签发

    供议付或其他付款方式使用，并供买方提货。

    官方页面
  • 输出许可证
    签发:
    国际贸易署或其他主管机关
    时点:
    货品分类表「输出规定」栏有相应代号时

    战略性高科技货品须取得输出许可，并注意最终用户与最终用途的规定。

    官方页面
  • 原产地证书
    签发:
    标准检验局、商工团体等签发机构
    时点:
    买方在进口地主张优惠或按规定需要时

    输往中国大陆早收清单货品适用 ECFA 原产地证明书；一般情形签发普通原产地证书。

    官方页面
  • 委任书
    签发:
    出口人
    时点:
    委托报关业者前

    报关业者据以代办出口报关与相关手续。

    官方页面
  • 检验或检疫证明
    签发:
    标准检验局（BSMI）、动植物防疫检疫署
    时点:
    属应施出口检验商品或应检疫货品时

    动植物及其产品的输出检疫证明，以及应施出口检验商品的报验合格证明。

    官方页面

美国 进口单证

  • CBP Form 3461（Entry/Immediate Delivery，放行申报表）
    签发:
    美国海关与边境保护局（CBP）
    时点:
    抵达时或抵达前，通过 ACE 电子传输

    放行用文件，一般可在抵达前 5 日内递交。

    官方页面
  • CBP Form 7501（Entry Summary，报关摘要表）
    签发:
    美国海关与边境保护局（CBP）
    时点:
    放行后 10 个工作日内

    载明 HTSUS 归类、完税价格与税额计算，可逐票缴纳或以按月汇总结算方式缴纳。

    官方页面
  • 商业发票
    签发:
    卖方或出口商
    时点:
    随报关单证

    应载明买卖双方、品名、数量、单价与总价、币种、贸易条件与原产地。

    官方页面
  • 装箱单
    签发:
    卖方或出口商
    时点:
    随报关单证

    逐箱内容、重量与唛头，查验时使用。

    官方页面
  • 提单（B/L）或空运单（AWB）
    签发:
    承运人或货运代理
    时点:
    装运时签发

    运输合同与提货权利的凭证。

    官方页面
  • 进口商安全申报（ISF 10+2）
    签发:
    进口商或其代理人
    时点:
    货物装船前至少 24 小时

    仅适用于海运货物，空运、公路与铁路运输不适用。

    官方页面
  • 海关保证金（单票或连续型）
    签发:
    美国财政部认可的担保机构
    时点:
    报关前设立

    正式报关与新设的邮递简易报关程序均须具备。

    官方页面
  • 自由贸易协定原产地声明
    签发:
    出口商、生产商或进口商
    时点:
    主张优惠税率时持有

    韩国原产货物适用美韩 FTA，采自我证明、无固定格式，报关时以特别方案代码 KR 主张。台湾地区与中国大陆同美国之间没有自由贸易协定。

    官方页面
  • 其他主管机构资料（PGA data）
    签发:
    FDA、USDA、FCC、CPSC、EPA 等
    时点:
    随报关单证

    例如食品的 FDA 事先通报（Prior Notice）、依 MoCRA 办理的化妆品工厂注册与产品列名并指定美国责任人、无线电设备的 FCC 符合性声明、儿童用品的 CPSC 证书。

    官方页面

6流程

  1. 装船前申报进口商或代理人在货物装船前至少 24 小时完成进口商安全申报（ISF 10+2），承运人也按同一 24 小时期限传输预报舱单。
  2. 递交报关单证通过 ACE 递交 CBP Form 3461，一般可在抵达前 5 日内申报。抵达后 15 个日历日内未申报的，货物将转入 General Order 仓库。
  3. 审核、查验与机构扣留CBP 可能指定单证审核、X 光或人工查验，FDA、USDA、CPSC 等主管机构也可能另行扣留。
  4. 放行CBP 与各机构的扣留解除后，货物即可放行离开港区。
  5. 报关摘要与缴税放行后 10 个工作日内递交 CBP Form 7501，并缴纳关税、商品处理费与港口维护费，可逐票或按月汇总结算缴纳。
  6. 税额确定（Liquidation）CBP 通常在报关后 314 日内确定税额。事后更正（post-summary correction）与异议（protest）另有期限。
  1. 预报舱单航空公司在抵达前传输预报货物信息。进口商安全申报（ISF）不适用于空运货物。
  2. 递交报关单证通过 ACE 递交 CBP Form 3461，多在航班落地前申报，以便抵达后尽快放行。
  3. 审核与机构扣留CBP 与其他主管机构审核申报，并可能在机场货运站查验。
  4. 放行提货放行后即可从航空货运站提取货物。
  5. 报关摘要与税额确定放行后 10 个工作日内处理 CBP Form 7501 与税款，之后比照海运货物办理税额确定。
  1. 预先传输数据快递企业或邮政机构在货物抵达前将数据传送 CBP。
  2. 报关自 2026-06-24 起，低价值货物不得再凭舱单放行。快件以简易报关（通常为 Entry Type 11）办理，超过 2,500 美元的必须办理正式报关。
  3. 邮递货物自 2026-07-24 起，价值 2,500 美元及以下且可归入 HTSUS 第 1 至 97 章的邮递货物，可适用邮递简易报关程序，由持照报关行或货物所有人、购买人申报，并须具备基本的进口与报关保证金。
  4. 税费计算与缴纳按申报价格计算关税与规费。快递企业通常先行垫付关税再向买方收取；邮递程序下，关税最迟应在包裹抵达次月 7 日前缴纳。
  5. 机构审查与派送食品、化妆品、药品、无线电设备与儿童用品仍须附送主管机构资料。涉及配额、反倾销或反补贴税、第 98 章或第 99 章关税，或主张自由贸易协定优惠的，不得使用邮递简易报关程序。
  1. 入境申报旅客以 CBP Form 6059B 或电子申报方式申报在境外取得的全部物品，并回答入境口岸 CBP 人员的询问。
  2. 个人免税额返美的美国居民一般享有 800 美元个人免税额；非居民随身携带、价值 200 美元及以下的个人与家用物品，依 19 U.S.C. 1321(a)(2)(B) 仍免税。
  3. 商业性货物为转售而携带的货物不适用个人免税额，须与一般进口同样办理简易或正式报关，其他主管机构的规定同样适用。
  4. 缴税超出免税额而申报的物品，其关税在旅客离开海关监管区前于入境口岸缴纳。
显示 台湾 出口侧流程
  1. 资格与规定查询确认已办妥出进口厂商登记，并在单一窗口查询货品分类号列与「输出规定」栏代号，判断是否需要输出许可、检验或检疫。
  2. 订舱与备货向船公司或货运代理订舱并取得装货单，完成包装与唛头，备齐发票、装箱单与必要证照。
  3. 报送出口报单由报关业者或出口人经关港贸单一窗口报送出口报单，系统按 C1／C2／C3 分流。
  4. 进场与查验货物进入集装箱集散站或码头，属 C3 的配合查验，必要时一并办理检验或检疫。
  5. 放行与装船取得放行后装船出口，并按规定完成结关。
  6. 后续申报取得提单办理收款，并以出口报单放行资料办理营业税零税率申报与冲退原料税。

7难度

建议委托报关行

分数: 0.92

这是依公开数据计算的信号，并非咨询意见。

判定理由

  • regime[FDA] Finished medicaments; if a controlled substance is present, DEA import registration/permit applies as well.(en)fda.gov2026-09-07
  • requirement2 destination import requirement(s) found: Medicaments (subset containing controlled substances) - DEA , Pharmaceutical products (medicaments, blood, dressings) - FD(en)dea.gov2026-09-07
  • ambiguityClassification is contested — rulings for this HS6 scatter across several subheadings and are often decided against neighbouring codes(en)rulings.cbp.gov2026-09-07
  • timingSince 2025-08-29 Executive Order 14324 has suspended duty-free de minimis entry for shipments from every country. Parcels are now dutiable and need an entry with HS classification and origin, which structurally raises difficulty for small consignments.(en)federalregister.gov2026-09-07

组成

进口要求0.76Medicaments (subset containing controlled substances) - DEA import registration/permit for scheduled-drug content. Substance-dependent, narrow. dea.govPharmaceutical products (medicaments, blood, dressings) - FDA-regulated drug/biologic (FD2). Potential/disclaimable flag; submit FDA entry data if FDA-regulated. fda.govconfidence=chapter-heuristic — CBP는 HS별 PGA 플래그 전량 공개 파일을 제공하지 않아 chapter/heading 휴리스틱 매핑을 사용함 customs_v0.sqlite:us_requirements
归类模糊度0.80US 결정례 1057건 · 하위 세번 103종으로 분산 rulings.cbp.govUS CROSS 1057건 중 복수 세번 결정 비율 21% · 같은 사건에서 함께 검토된 다른 HS6 66개 rulings.cbp.gov
管制制度1.00FDA drug (+ DEA if controlled) fda.gov
台湾 出口侧备注: Taiwan export rules 522, 523, 801, 804 — check whether an agency approval or licence is needed to export. portal.sw.nat.gov.tw

数据日期: 2026-09-07

8案例

显示其他国家的案例 (30)

来源: Federal Register: Indefinite Suspension of the De Minimis Exemption for Merchandise Arriving Through All Modes Other Than the International Postal Network · Federal Register: Indefinite Suspension of the De Minimis Exemption for Mail Shipments and New Postal Informal Entry Process · Federal Register: Notice of Implementation of Executive Order 14324, Suspending Duty-Free De Minimis Treatment for All Countries · CBP Form 7501, Entry Summary (revision 02/26) · CBP: Importer Security Filing (10+2) · Harmonized Tariff Schedule of the United States · Supreme Court of the United States: Learning Resources, Inc. v. Trump (No. 24-1287) · FDA: Registration and Listing of Cosmetic Product Facilities and Products · 台湾关港贸单一窗口 · 台湾关务署 — 各项货品输出入规定 · 台湾国际贸易署 — 货品分类管理系统注意事项 · 台湾国际贸易署 · 台湾财政部 — 更新 ECFA 早收清单税则对照表 · 台湾标准检验局

身份: 个人／小卖家 — 会改变页面强调的板块